Can-Fite BioPharma Ltd. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Can-Fite BioPharma Ltd. (CANF) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$5.10 million for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-26.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2021-08-26
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|
| 2021-06-30 | -$5.10M 6-K · filed 2021-08-26 | ||
| 2020-06-30 | -$8.23M 6-K · filed 2021-08-26 | ||
| 2019-12-31 | -$12.63M 6-K · filed 2020-06-01 | ||
| 2018-12-31 | -$6.57M 6-K · filed 2020-06-01 | ||
| 2017-12-31 | -$4.84M 6-K · filed 2020-06-01 | -$6.43M 6-K · filed 2018-08-08 | |
| 2016-12-31 | -$8.39M 6-K · filed 2018-08-08 | ||
| 2015-12-31 | -$6.51M 6-K · filed 2018-08-08 |